The Government of the United States has a website called ‘USA Spending‘, an official open data source of federal spending information. According to the site as of 12th April 2021, the US Government has spent a mind-blowing $3.63 trillion “in response to COVID-19”. But that’s not the only information on Covid that can be found on the site.

Hidden within the ‘Award Search’ are details on a contract awarded by the Department of Defense to a company named ‘Black & Veatch Special Projects Corp‘, which is allegedly “a global engineering, procurement, consulting and construction company specialising in infrastructure development”.

• DoD’s 17 Year Old Agreement Confirms “Dangerous Pathogens Located At The Facilities In Ukraine” Funded With Our Money
• Did The Department of Defense Bury Data On COVID Shot Injuries To Continue Murdering US Troops? (Video)
• Trump Department Of Defense & DARPA Partnering With Bill Gates For New DNA Nanotech COVID-19 Vaccine (Video)
• Executive Order Initiates ‘Department Of Defense Global Campaign Plan For Pandemic Influenza And Infectious Diseases 3551-13’
• Why Is The Defense Department Purchasing 500 Million ApiJect Syringes? Military Vaccination Mandates?
• 40 Groups Demand Congress Investigate “Gross Misuse” Of $1Billion COVID Funding By Pentagon Alleged To Be “Colossal Backdoor Bailout For Defense Industry”

The contract was awarded on September 20th, 2012 and is described as “Professional, Scientific, and Technical Services”. Obviously, this is very vague and most likely of little interest to anyone who happens to stumble across it. But there is something contained deep within the details that should be of interest to anyone and everyone.

The ‘Award History’ for the contract contains a tab for ‘Sub-Awards’ detailing the recipients, action date, amount, and a very brief description for 115 Sub-Award transactions. Most of the Sub-Awards are extremely mundane for things such as “laboratory equipment for Kyiv”, or “office furniture for Kyiv”.

But there is one Sub-Award that stands out among the rest, and it was awarded to Labyrinth Global Health INC for “SME Manuscript Documentation and COVID-19 Research”.

An award for Covid-19 research isn’t exactly shocking when the world is allegedly in the grip of a Covid-19 pandemic, but considering the fact the sub-contract was awarded 12th November 2019, at least one month before the alleged emergence of the novel coronavirus, and three months before it was officially dubbed Covid-19, the award for Covid-19 research should come as a shock to everyone.

But the shock doesn’t end there, because the place the contact for Covid-19 research was instructed to take place was Ukraine, as was the entire contract awarded by the DOD to Black & Veatch Special Projects Corp.

The contract details found on the ‘USA Spending’ site actually reveal that the specific DOD department that awarded the contract was the Defense Threat Reduction Agency (DTRA). The contract was awarded 20th September 2012, and concluded on 13th October 2020.

Whilst the details are vague, the US Government site also reveals that $21.7 million of the $116.6 million contract was spent on a ‘Biological threat reduction program in Ukraine’.

Why did the Department of Defense pay a company that is allegedly “a global engineering, procurement, consulting and construction company specialising in infrastructure development”, to help implement a “Biological threat reduction program in Ukraine’?

And why did both the DOD and said company then pay Labyrinth Global Health INC to carry out COVID-19 research in Ukraine at least one month before the alleged emergence of the novel coronavirus, and three months before it was officially dubbed Covid-19?

Founded in 2017, Labyrinth Global Health is allegedly a “women-owned small business with deep expertise and a proven track record supporting initiatives for scientific and medical advancement.”

They describe themselves as “a multicultural and international organization with offices in four countries and a team of experts with diverse backgrounds and competencies, including microbiology, virology, global health, emerging infectious disease nursing, medical anthropology, field epidemiology, clinical research, and health information systems.”

One of those offices just happens to be located in Kyiv, Ukraine, which the company dubs “a gateway to Eastern Europe”.

The leadership team of Labyrinth Global consists of Karen Saylors, PHD who is the Chief Executive Officer; Mary Guttieri, PHS who is the Chief Science Officer; and Murat Tartan who is the Chief Financial Officer.

Karen Saylors, PhD, who co-founded Labyrinth Global Health, has allegedly worked in the international public health field for over a decade and has spent many years living in Africa establishing global surveillance networks, “working with partners to improve Global Health policy on infectious disease detection, response, and control”.

At Labyrinth, Dr Saylors specialises in studies that aim to understand and mitigate the biological and behavioural risks of disease transmission. Dr Saylors worked with Oxford University Clinical Trials Network in Vietnam on zoonotic disease surveillance research and continues to coordinate with regional partners on emerging outbreaks in animal and human populations.

But who are the partners that Dr Karen Saylors and Labyrinth Global Health choose to work with? They are none other than the ‘Eco-Health Alliance’ and ‘Metabiota’.

Dr Karen Saylors, Eco-Health Alliance and Metabiota worked together on the United States Agency for International Development (USAID) ‘PREDICT’ program from 2009, while Labyrinth Global Health worked alongside EHA and Metabiota on the PREDICT program from 2017.

Launched in 2009 and funded by USAID, PREDICT was an early warning system for new and emerging diseases in 21 countries. It was led by the University of California’s (“UC”) Davis One Health Institute and core partners included EcoHealth Alliance (“EHA”), Metabiota, Wildlife Conservation Society, and Smithsonian Institution, and as we’ve just revealed; Labyrinth Global Health. PREDICT was a forerunner of the more ambitious Global Virome Project.

The USAID describes PREDICT as having made “significant contributions to strengthening global surveillance and laboratory diagnostic capabilities for both known and newly discovered viruses within several important virus groups, such as filoviruses (including ebolaviruses), influenza viruses, paramyxoviruses, and coronaviruses“.

Here’s one of the many studies published by Eco Health Alliance, Metabiota and Labyrinth Global Health proving the connection –

PREDICT partnered with the non-profit Eco Health Alliance (EHA) to carry out its 9-year effort to catalogue hundreds of thousands of biological samples, “including over 10,000 bats.” A PREDICT-funded 2015 study on “diversity of coronavirus in bats” also included Peter Daszak, president of EHA, among its participants.

Eco Health Alliance is listed as a partner of the Wuhan Institute of Virology (“WIV”) on archived pages of its website and was mentioned as one of the institute’s “strategic partners” by the WIV’s Deputy Director-General in 2018.

Notably, the relationship between the WIV and the American Biodefense establishment was advanced by EHA policy advisor, David R. Franz, former commander at the US bioweapons lab at Fort Detrick.

WIV’s Dr. Shi Zhengli, a.k.a. “Batwoman,” had also worked with EHA’s Daszak on bat-related studies. As far back as 2005, Daszak and Zhengli were conducting research on SARS-like coronaviruses in bats. Several PREDICT-funded studies on SARS-like coronaviruses and Swine Flu count with both Zhengli’s and Daszak’s contributions. Perhaps the most noteworthy of these is a 2015 PREDICT and NIH-funded study she co-authored entitled: ‘A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence’.

Meanwhile, Nathan Wolfe is the founder of Metabiota and the non-profit Global Viral. He spent over eight years conducting biomedical research in both sub-Saharan Africa and Southeast Asia. Unsurprisingly, Wolfe is a World Economic Forum Young Global Leader.  More notably, since 2008 he had been a member of DARPA’s DSRC, Defence Science Research Council, until it was disbanded.

All of these people and organisations have been working for at least the last decade studying coronaviruses and helping to set up Biolabs in Ukraine. All using US Department of Defense funds to do so. You can read much more about this here, here and here.

Putting the Biolabs in Ukraine to one side, for now, let’s return to the subject of Covid-19. If the US Government was funding Covid-19 research before Covid-19 was publicly known to exist then this suggests they either knew Covid-19 existed naturally, or they were involved in constructing this virus in a lab.

But if the contract evidence isn’t enough for you to come to this conclusion (it should be), then perhaps coupling it with evidence that the US National Institute of Allergy & Infectious Diseases (NIAID), and Moderna had a coronavirus candidate in December 2019 will be.

A confidentiality agreement which can be viewed here, states that providers ‘Moderna’ alongside the ‘National Institute of Allergy and Infectious Diseases (NIAID) agreed to transfer ‘mRNA coronavirus vaccine candidates’ developed and jointly-owned by NIAID and Moderna to recipients ‘The University of North Carolina at Chapel Hill’ on the 12th December 2019.

The material transfer agreement was signed the December 12th 2019 by Ralph Baric, PhD, at the University of North Carolina at Chapel Hill, and then signed by Jacqueline Quay, Director of Licensing and Innovation Support at the University of North Carolina on December 16th 2019.

The agreement was also signed by two representatives of the NIAID, one of whom was Amy F. Petrik PhD, a technology transfer specialist who signed the agreement on December 12th 2019 at 8:05 am. The other signatory was Barney Graham MD PhD, an investigator for the NIAID, however, this signature was not dated.

The final signatories on the agreement were Sunny Himansu, Moderna’s Investigator, and Shaun Ryan, Moderna’s Deputy General Councel. Both signautres were made on December 17th 2019.

All of these signatures were made prior to any knowledge of the alleged emergence of the novel coronavirus. It wasn’t until December 31st 2019 that the World Health Organisation (WHO) became aware of an alleged cluster of viral pneumonia cases in Wuhan, China. But even at this point, they had not determined that an alleged new coronavirus was to blame, instead stating the pneumonia was of “unknown cause”.

All of this requires much further research to fit all of the pieces of the puzzle together, but here’s what we definitely know so far –

• A novel coronavirus emerged in Wuhan in December 2019.
• The world did not get to hear about this novel coronavirus until early January 2020.
• The world did not know this novel coronavirus was called Covid-19 until February 2020, when the World Health Organization officially named it so.
• The US Department of Defense awarded a contract for Professional, Scientific, and Technical Services to Black & Veatch Special Projects Corp‘, which is allegedly “a global engineering, procurement, consulting and construction company specialising in infrastructure development”.
• That contract involved a Biological threat reduction program in Ukraine.
• As part of this larger contract, another contract was awarded to Labyrinth Global Health for ‘COVID-19 Research’ on 12th November 2019.
• This was awarded at least one month before the alleged emergence of the novel coronavirus, and three months before it was officially dubbed Covid-19.
• Labyrinth Global Health works alongside the ‘Eco Health Alliance’, and ‘Metabiota’, and participated in the USAID PREDICT program. All of these people and organisations have been working for at least the past decade studying coronaviruses and helping to set up Biolabs in Ukraine. All using US Department of Defense funds to do so.
• Information found here points to Eco Health Alliance having a hand in creating the Covid-19 virus.
• Information found here points to Moderna having a hand in creating the Covid-19 virus.
• ‘Moderna’, alongside the ‘National Institute of Allergy and Infectious Diseases’ (NIAID) agreed to tranfer ‘mRNA coronavirus vaccine candidates’ developed and jointly-owned by NIAID and Moderna, to recipients ‘The University of North Carolina at Chapel Hill’ on the 12th December 2019.